Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 12 M12.54 M13.87 M19.21 M15.75 M 61.38 M Research & development ————— — Operating income 52.35 M93.76 M148.65 M224.99 M223.11 M 690.5 M Non-Operating Income, Total -7.34 M-3.49 M6.96 M-31.66 M-7.55 M -35.74 M Interest expense, net of interest capitalized 11.55 M11.1 M13.4 M-77.48 M5.66 M -47.32 M Non-Operating Income, excl. Interest Expenses -19.83 M-16.1 M-8.88 M51.43 M-16.76 M 9.7 M Unusual income/expense 942 K1.51 M2.43 M-5.61 M3.55 M 1.88 M Pretax income 45.02 M90.27 M155.6 M193.33 M215.55 M 654.76 M Equity in earnings ————— — Taxes 16.14 M32.56 M54.88 M54.39 M50.9 M 192.73 M Non-controlling/minority interest ————— — After tax other income/expense -507 K2.19 M-4.52 M-9.07 M-1.76 M -13.16 M Net income before discontinued operations 28.87 M57.7 M100.73 M134.41 M-202.71 M 90.13 M Discontinued operations ————183.68 M — Net income 28.87 M57.7 M100.73 M134.41 M-19.03 M 273.81 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 28.73 M57.57 M100.59 M134.27 M-19.16 M 273.27 M Basic earnings per share (Basic EPS) 0.050.090.150.2-0.03 0.41 Diluted earnings per share (Diluted EPS) 0.050.090.150.2-0.03 0.41 Average basic shares outstanding 632.05 M636.93 M669.19 M651.97 M670.39 M — Diluted shares outstanding 634.71 M639.74 M671.94 M655.77 M675.15 M — EBITDA 91.53 M140.24 M198.02 M259.15 M257.57 M 854.98 M EBIT 52.35 M93.76 M148.65 M220.04 M223.11 M 685.55 M Cost of revenue 187.34 M184.5 M229.07 M199.9 M158.18 M 771.66 M Other cost of goods sold 1.56 M812 K51 K10.59 M0 11.45 M Depreciation & amortization (cash flow) 39.17 M46.48 M49.38 M39.11 M34.47 M 169.44 M